Genzyme CorporateSearchGenzyme Websites
Gaucher Disease Treatment Information for Patients and Families Gaucher Disease Treatment Information for Healthcare Providers
Gaucher Community

The Gaucher Registry

The International Collaborative Gaucher Group (ICGG) Gaucher Registry is, the largest ongoing longitudinal international database that tracks demographic and clinical outcome data from patients with Gaucher disease. The Gaucher Registry, sponsored by Genzyme, was established in 1991.

The Registry includes more than 4,000 patients and is open to all patients worldwide, irrespective of treatment status. Scientific direction is provided to the Registry by an independent group of international physicians, the ICGG Regional Coordinators.[1]

The Gaucher Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Gaucher disease. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient’s treating physician.

The objectives of the Registry are:

To enhance the understanding of the variability, progression, and natural history of Gaucher disease with the ultimate goal of better guiding and assessing therapeutic interventions;
To provide the Gaucher medical community with recommendations for monitoring patients and to provide reports on patient outcomes to help optimize patient care; and
To evaluate the long-term effectiveness of enzyme replacement therapy (ERT).

Publications have been generated on patient demographics, disease characteristics, outcomes, guidelines on diagnosis, initial assessment and ongoing monitoring.

The Registry’s patient case reports offer a valuable tool that enables participating physicians to monitor response to therapy and disease progression. The reports graphically summarize the changes in clinical parameters such as bone involvement or organ volume changes over time. Patient case reports can help motivate patients to comply with their treatment plan and establish a foundation for their long-term care.

Visit http://www.gaucherregistry.com to learn more.

References:

1. The Gaucher Registry. Data on File.


Did you know...

Doctors diagnose Gaucher disease by using a simple blood test called an enzyme assay. The assay for Gaucher disease measures activity levels of the enzyme glucocerebrosidase in white blood cells or skin cells. Individuals who are affected with Gaucher disease will have very low levels of enzyme activity. However, the assay cannot determine disease severity. Learn more in Diagnosing and Testing >>


Genzyme USA
500 Kendall Street
Cambridge, MA 02142 USA
617 768 9000
800 745 4447

Genzyme Europe BV
Gooimeer 10
1411 DD Naarden
The Netherlands
31 35 699 1200

Contact Genzyme